XML 15 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Total
Balance at Dec. 31, 2014 $ 1,360,668 $ 124 $ (919,577) $ 441,215
Balance (in shares) at Dec. 31, 2014 300,100,000      
Increase (Decrease) in Shareholders' Equity        
Stock-based compensation (note 9) $ 1,047     1,047
Return of capital distribution (note 8) (1,503)     (1,503)
Shares issued for the settlement of accounts payable (note 8) $ 443     443
Shares issued for settlement of accounts payable (note 8) (in shares) 430,000      
Unrealized gain (loss) on available-for-sale securities, net of taxes (note 2)   (1,126)   (1,126)
Net income     (5,462) (5,462)
Balance at Sep. 30, 2015 $ 1,360,655 (1,002) (925,039) 434,614
Balance (in shares) at Sep. 30, 2015 300,530,000      
Balance at Dec. 31, 2014 $ 1,360,668 124 (919,577) 441,215
Balance (in shares) at Dec. 31, 2014 300,100,000      
Increase (Decrease) in Shareholders' Equity        
Share repurchase (note 8)       $ (1,800)
Share repurchase (note 8) (in shares)       (1,896,442)
Balance at Dec. 31, 2015 $ 1,359,144 (825) (940,027) $ 418,292
Balance (in shares) at Dec. 31, 2015 298,634,000      
Increase (Decrease) in Shareholders' Equity        
Stock-based compensation (note 9) $ 770     770
Return of capital distribution (note 8) (2,986)     (2,986)
Exercise of stock options (note 8) $ 3,500     3,500
Exercise of stock options (note 8) (in shares) 1,377,000      
Share repurchase (note 8) $ (582)     $ (582)
Share repurchase (note 8) (in shares) (558,000)     (557,991)
Other-than-temporary impairment on marketable equity securities (note 2)   882   $ 882
Unrealized gain (loss) on available-for-sale securities, net of taxes (note 2)   1,790   1,790
Net income     25,546 25,546
Balance at Sep. 30, 2016 $ 1,359,846 $ 1,847 $ (914,481) $ 447,212
Balance (in shares) at Sep. 30, 2016 299,453,000